Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Aspire Biopharma Holdings, Inc.

  • ESTERO, Florida
  • Public · NASDAQ: ASBP
$6.9MMarket cap
$6.2KRevenue · FY2025
-$24.5MNet income
ASBPNASDAQ
2025IPO

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$6.2K
Net income
-$24.5M
Total assets
$1.3M
Market cap
$6.9M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: ASBP

15-minute delayed · data by Polygon.io

Market cap
$6.9M
Open
Day range
Prev close
Volume
IPO date
Feb 20, 2025

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Aspire Biopharma Holdings, Inc..

Write a review
Explore

Similar companies

Browse all →